ASX:MVPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
MEDICAL DEVELOPMENTS INTERNATNL ORD
$0.430
$0.010 (2.27%)
Day Range
$0.430 - $0.450
52 Week Range
$0.365 - $0.765
Volume
41.27K
Avg Volume (10D)
63.57K
Market Cap
$48.44M
P/E Ratio
523.81
Price Chart
Market Statistics
Open$0.450
Previous Close$0.440
Day High$0.450
Day Low$0.430
52 Week High$0.765
52 Week Low$0.365
Valuation
Market Cap48.44M
Shares Outstanding112.66M
P/E Ratio (Annual)523.81
Price to Book0.91
Trading Activity
Volume41.27K
Value Traded18.19K
Bid$0.430 × 30,611
Ask$0.440 × 4,392
Performance
1 Day1.15%
5 Day-3.30%
13 Week-5.38%
52 Week-29.03%
YTD-20.72%
Technical Indicators
RSI (14)49.17
50-Day SMA$0.415
200-Day SMA$0.540
Latest News
Biotechnology
Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
1 min read
Biotechnology
Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]
4 min read
